UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 22, 2022
Accession Number:
Submission Type:
CIK: 0001621227
Company Name: Adaptimmune Therapeutics PLC
File Number: 333-264208